Cancer systems biology

A peek into the future of patient care?

Henrica M J Werner, Gordon Mills, Prahlad T. Ram

Research output: Contribution to journalReview article

73 Citations (Scopus)

Abstract

Traditionally, scientific research has focused on studying individual events, such as single mutations, gene function, or the effect that mutating one protein has on a biological phenotype. A range of technologies is beginning to provide information that will enable a holistic view of how genomic and epigenetic aberrations in cancer cells can alter the homeostasis of signalling networks within these cells, between cancer cells and the local microenvironment, and at the organ and organism level. This process, termed Systems Biology, needs to be integrated with an iterative approach wherein hypotheses and predictions that arise from modelling are refined and constrained by experimental evaluation. Systems biology approaches will be vital for developing and implementing effective strategies to deliver personalized cancer therapy. Specifically, these approaches will be important to select those patients who are most likely to benefit from targeted therapies and for the development and implementation of rational combinatorial therapies. Systems biology can help to increase therapy efficacy or bypass the emergence of resistance, thus converting the current - often short term - effects of targeted therapies into durable responses, ultimately to improve patient quality of life and provide a cure.

Original languageEnglish (US)
Pages (from-to)167-176
Number of pages10
JournalNature Reviews Clinical Oncology
Volume11
Issue number3
DOIs
StatePublished - Mar 1 2014
Externally publishedYes

Fingerprint

Systems Biology
Patient Care
Neoplasms
Cellular Microenvironment
Therapeutics
Epigenomics
Homeostasis
Quality of Life
Technology
Phenotype
Mutation
Research
Genes
Proteins

ASJC Scopus subject areas

  • Oncology

Cite this

Cancer systems biology : A peek into the future of patient care? / Werner, Henrica M J; Mills, Gordon; Ram, Prahlad T.

In: Nature Reviews Clinical Oncology, Vol. 11, No. 3, 01.03.2014, p. 167-176.

Research output: Contribution to journalReview article

Werner, Henrica M J ; Mills, Gordon ; Ram, Prahlad T. / Cancer systems biology : A peek into the future of patient care?. In: Nature Reviews Clinical Oncology. 2014 ; Vol. 11, No. 3. pp. 167-176.
@article{ce86a7e1eec84005a320639b2b59e952,
title = "Cancer systems biology: A peek into the future of patient care?",
abstract = "Traditionally, scientific research has focused on studying individual events, such as single mutations, gene function, or the effect that mutating one protein has on a biological phenotype. A range of technologies is beginning to provide information that will enable a holistic view of how genomic and epigenetic aberrations in cancer cells can alter the homeostasis of signalling networks within these cells, between cancer cells and the local microenvironment, and at the organ and organism level. This process, termed Systems Biology, needs to be integrated with an iterative approach wherein hypotheses and predictions that arise from modelling are refined and constrained by experimental evaluation. Systems biology approaches will be vital for developing and implementing effective strategies to deliver personalized cancer therapy. Specifically, these approaches will be important to select those patients who are most likely to benefit from targeted therapies and for the development and implementation of rational combinatorial therapies. Systems biology can help to increase therapy efficacy or bypass the emergence of resistance, thus converting the current - often short term - effects of targeted therapies into durable responses, ultimately to improve patient quality of life and provide a cure.",
author = "Werner, {Henrica M J} and Gordon Mills and Ram, {Prahlad T.}",
year = "2014",
month = "3",
day = "1",
doi = "10.1038/nrclinonc.2014.6",
language = "English (US)",
volume = "11",
pages = "167--176",
journal = "Nature Reviews Clinical Oncology",
issn = "1759-4774",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Cancer systems biology

T2 - A peek into the future of patient care?

AU - Werner, Henrica M J

AU - Mills, Gordon

AU - Ram, Prahlad T.

PY - 2014/3/1

Y1 - 2014/3/1

N2 - Traditionally, scientific research has focused on studying individual events, such as single mutations, gene function, or the effect that mutating one protein has on a biological phenotype. A range of technologies is beginning to provide information that will enable a holistic view of how genomic and epigenetic aberrations in cancer cells can alter the homeostasis of signalling networks within these cells, between cancer cells and the local microenvironment, and at the organ and organism level. This process, termed Systems Biology, needs to be integrated with an iterative approach wherein hypotheses and predictions that arise from modelling are refined and constrained by experimental evaluation. Systems biology approaches will be vital for developing and implementing effective strategies to deliver personalized cancer therapy. Specifically, these approaches will be important to select those patients who are most likely to benefit from targeted therapies and for the development and implementation of rational combinatorial therapies. Systems biology can help to increase therapy efficacy or bypass the emergence of resistance, thus converting the current - often short term - effects of targeted therapies into durable responses, ultimately to improve patient quality of life and provide a cure.

AB - Traditionally, scientific research has focused on studying individual events, such as single mutations, gene function, or the effect that mutating one protein has on a biological phenotype. A range of technologies is beginning to provide information that will enable a holistic view of how genomic and epigenetic aberrations in cancer cells can alter the homeostasis of signalling networks within these cells, between cancer cells and the local microenvironment, and at the organ and organism level. This process, termed Systems Biology, needs to be integrated with an iterative approach wherein hypotheses and predictions that arise from modelling are refined and constrained by experimental evaluation. Systems biology approaches will be vital for developing and implementing effective strategies to deliver personalized cancer therapy. Specifically, these approaches will be important to select those patients who are most likely to benefit from targeted therapies and for the development and implementation of rational combinatorial therapies. Systems biology can help to increase therapy efficacy or bypass the emergence of resistance, thus converting the current - often short term - effects of targeted therapies into durable responses, ultimately to improve patient quality of life and provide a cure.

UR - http://www.scopus.com/inward/record.url?scp=84896705997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896705997&partnerID=8YFLogxK

U2 - 10.1038/nrclinonc.2014.6

DO - 10.1038/nrclinonc.2014.6

M3 - Review article

VL - 11

SP - 167

EP - 176

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

SN - 1759-4774

IS - 3

ER -